Furthermore, the group treated with GLP-1-R agonists experienced fewer headache days than the other group while the dose of acetazolamide was reduced
Being a leader in microneedling TDDS, their unique micro needle technology, DEN (Droplet Extension Needle), allows them to transfer drugs through a soluble micro needle. Raphas has FDA cGMP manufacturing validation for microneedle skin patches and has completed Phase 1 clinical trials
When combined with healthy nutrition and regular physical activity, GLP1 injections can promote gradual, sustainable weight loss
It is important to note that real-world results from these therapies often differ from the results from controlled clinical trials
Batch-specific Certificates of Analysis and purity reports are publicly available for our products
The global obesity GLP-1 market is valued at USD 8,169 million in 2025